on VALBIOTIS (EPA:ALVAL)
Valbiotis - Combined Annual General Meeting of June 25, 2024: Voting results
On June 25, 2024, Valbiotis held its Combined Annual General Meeting in La Rochelle, under the chairmanship of Sébastien Peltier. Valbiotis is a French laboratory specializing in food supplements for the prevention of metabolic disorders and cardiovascular diseases.
Shareholders adopted resolutions 1 to 4 and 17, while resolutions 5 to 16 were rejected. The meeting took place at the Hôtel La Fabrique.
For more information, the details of this assembly are available on the official Valbiotis website.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news